Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
Journal of Hospital Medicine|June 6, 2022
Clinical and virologic factors associated with outcomes of COVID-19 before and after vaccination among Veterans: Retrospective analysis from six New England statesMegan Lee, Danielle Cosentino, Tassos C Kyriakides, et al.Journal of Clinical Gastroenterology|October 24, 2012
KRAS mutations are associated with specific morphologic features in colon cancerArmagan Gunal, Pei Hui, Selim Kilic, et al.Plos One|August 29, 2023
Correlation of a commercial platform's results with post-vaccination SARS-CoV-2 neutralizing antibody response and clinical host factorsRebecca Slotkin, Tassos C Kyriakides, Anupam Kundu, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|March 16, 2010
Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotypingCarleta B Maurice, Pankaj K Barua, Diane Simses, et al.BMC Research Notes|June 23, 2012
Comparison of PCR-based detection of chromogranin A mRNA with traditional histological lymph node staging of small intestinal neuroendocrine neoplasiaBen Lawrence, Barton Kenney, Bernhard Svejda, et al.British Journal of Pharmacology|October 1, 2003
WAY-855 (3-amino-tricyclo[2.2.1.02.6]heptane-1,3-dicarboxylic acid): a novel, EAAT2-preferring, nonsubstrate inhibitor of high-affinity glutamate uptakeJohn Dunlop, Scott Eliasof, Gary Stack, et al.The Journal of Pharmacology and Experimental Therapeutics|August 4, 2007
Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporterJohn N Mason, Darlene C Deecher, Rhonda L Richmond, et al.Brain Research|January 25, 2006
Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503Sharon Rosenzweig-Lipson, Jean Zhang, Hossein Mazandarani, et al.Plos One|August 7, 2020
SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent?Daniel G Federman, Shaili Gupta, Gary Stack, et al.Psychopharmacology|December 25, 2008
WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychoticsSteven M Grauer, Radka Graf, Rachel Navarra, et al.Pageof 6